Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
AACC/NKF Guidance Document on Improving Equity in Chronic Kidney Disease Care
by
Palmer, Octavia Peck
, Hoenig, Melanie P
, Marzinke, Mark A
, Greene, Dina N
, Pierre, Christina C
, Vassalotti, Joseph
, Lorey, Thomas
, Palevsky, Paul M
, Collister, David
, Colón-Franco, Jessica M
, Ahmed, Sofia B
, Whitley, Cameron T
, Rosas, Sylvia E
in
Blood levels
/ Creatinine
/ Cystatin C
/ Epidermal growth factor receptors
/ Gender
/ Glomerular filtration rate
/ Kidney diseases
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
AACC/NKF Guidance Document on Improving Equity in Chronic Kidney Disease Care
by
Palmer, Octavia Peck
, Hoenig, Melanie P
, Marzinke, Mark A
, Greene, Dina N
, Pierre, Christina C
, Vassalotti, Joseph
, Lorey, Thomas
, Palevsky, Paul M
, Collister, David
, Colón-Franco, Jessica M
, Ahmed, Sofia B
, Whitley, Cameron T
, Rosas, Sylvia E
in
Blood levels
/ Creatinine
/ Cystatin C
/ Epidermal growth factor receptors
/ Gender
/ Glomerular filtration rate
/ Kidney diseases
2023
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
AACC/NKF Guidance Document on Improving Equity in Chronic Kidney Disease Care
by
Palmer, Octavia Peck
, Hoenig, Melanie P
, Marzinke, Mark A
, Greene, Dina N
, Pierre, Christina C
, Vassalotti, Joseph
, Lorey, Thomas
, Palevsky, Paul M
, Collister, David
, Colón-Franco, Jessica M
, Ahmed, Sofia B
, Whitley, Cameron T
, Rosas, Sylvia E
in
Blood levels
/ Creatinine
/ Cystatin C
/ Epidermal growth factor receptors
/ Gender
/ Glomerular filtration rate
/ Kidney diseases
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
AACC/NKF Guidance Document on Improving Equity in Chronic Kidney Disease Care
Journal Article
AACC/NKF Guidance Document on Improving Equity in Chronic Kidney Disease Care
2023
Request Book From Autostore
and Choose the Collection Method
Overview
Abstract
Background
Kidney disease (KD) is an important health equity issue with Black, Hispanic, and socioeconomically disadvantaged individuals experiencing a disproportionate disease burden. Prior to 2021, the commonly used estimated glomerular filtration rate (eGFR) equations incorporated coefficients for Black race that conferred higher GFR estimates for Black individuals compared to non-Black individuals of the same sex, age, and blood creatinine concentration. With a recognition that race does not delineate distinct biological categories, a joint task force of the National Kidney Foundation and the American Society of Nephrology recommended the adoption of the CKD-EPI 2021 race-agnostic equations.
Content
This document provides guidance on implementation of the CKD-EPI 2021 equations. It describes recommendations for KD biomarker testing, and opportunities for collaboration between clinical laboratories and providers to improve KD detection in high-risk populations. Further, the document provides guidance on the use of cystatin C, and eGFR reporting and interpretation in gender-diverse populations.
Summary
Implementation of the CKD-EPI 2021 eGFR equations represents progress toward health equity in the management of KD. Ongoing efforts by multidisciplinary teams, including clinical laboratorians, should focus on improved disease detection in clinically and socially high-risk populations. Routine use of cystatin C is recommended to improve the accuracy of eGFR, particularly in patients whose blood creatinine concentrations are confounded by processes other than glomerular filtration. When managing gender-diverse individuals, eGFR should be calculated and reported with both male and female coefficients. Gender-diverse individuals can benefit from a more holistic management approach, particularly at important clinical decision points.
Publisher
Oxford University Press
This website uses cookies to ensure you get the best experience on our website.